Dstock,
You may be right, but I really don't think the expansion at BP's is specifically for NWBO, though it's possible that part of it could play into either partnership or buyout. I still believe the CRL facility in Memphis will play a big part once we have approvals outside the UK and EU. I don't doubt that one or more BP's have spoken with LP, but I don't believe anything is so firm that they're investing in production facilities purely for DCVax-L. There is no doubt that biologics will play a bigger part of the entire industry, and I do expect that over time more truly personalized products will be developed, but BP's will go screaming and kicking into that world, they still want to market mass produced products.
I certainly could be wrong, for all I know all that needs to happen is certain key events and a BP has already agreed to all the terms of a partnership or buyout at prices that are already established. While I don't think so, anything is possible. If I'm wrong, the key event might be as little as UK approval, to as much as certification of the EDEN unit and approval of all four regulators, or even more. It's also possible that it's keyed to a specific stock price, regardless of how it's achieved. Generally companies don't pay more than double the current share price, but occasionally they'll pay more than that, but you won't see $20 a share for a $2 stock, maybe $7, but that would be a stretch IMHO unless it came with news that would have driven the stock to $10 or more without the partnership or buyout.
Right now the key is gaining UK approval, after that I think a lot of things will start to fall into place. Things will be happening while we're waiting for the UK action, but it will be the first really big news IMHO.
Gary
